MRDagent: iterative and adaptive parameter optimization for stable ctDNA-based MRD detection in heterogeneous samples
Bioinformatics · 2025
DOI: 10.1093/bioinformatics/btaf485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics, 2025. Verfasst von Tianci Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, China. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Neoplasm, Residual, Software, Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Motivation Minimal residual disease (MRD) as critical biomarker for cancer prognosis and management plays a crucial role in improving patient outcomes. However, detecting MRD via next-generation sequencing-based circulating tumor DNA variant calling remains unstable due to the extremely low variant allele frequency and significant inter- and intra-sample heterogeneity. Although parameter optimization can theoretically enhance the detection performance of variants, achieving stable MRD detection remains challenging due to three key factors: (i) the necessity for individualized parameter tuning across numerous heterogeneous genomic intervals within each sample, (ii) the tightly interdependent parameter requirements across different stages of variant detection workflows, and (iii) the limitations of current automated parameter optimization methods. Results In this study, we propose MRDagent, a novel variant detection tool designed specifically for MRD detection. MRDagent incorporates an iterative and self-adaptive optimization framework capable of handling unknown objectives, varying constraints, and highly coupled parameters across stages. A key innovation of MRDagent is the integration of a convolutional neural network-based meta-model, trained on historical data to enable rapid parameter prediction. This significantly enhances computational efficiency and generalization performance. Extensive evaluations on simulated and real-world datasets demonstrate MRDagent’s superior and stable performance, providing an efficient, reliable solution for MRD detection in clinical and high-throughput research applications. Availability and implementation MRDagent is freely available at https://github.com/aAT0047/MRDagent.git. The corresponding dataset and software archive are available at Zenodo: https://doi.org/10.5281/zenodo.15458496.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, China.
- Shaanxi Engineering Research Center of Medical and Health Big Data, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, China.
- Department of Respiratory Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, No. 157, Xiwu Road, Xincheng District, Xi'an, Shaanxi, 710003, China.
ORCID-Profile: Tianci Wang, Jiayin Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, T., Lai, X., Wang, S., Liu, Y., Zhu, X., & Wang, J. (2025). MRDagent: iterative and adaptive parameter optimization for stable ctDNA-based MRD detection in heterogeneous samples. Bioinformatics. https://doi.org/10.1093/bioinformatics/btaf485
Vancouver
Wang T, Lai X, Wang S, Liu Y, Zhu X, Wang J. MRDagent: iterative and adaptive parameter optimization for stable ctDNA-based MRD detection in heterogeneous samples. Bioinformatics. 2025. doi:10.1093/bioinformatics/btaf485
BibTeX
@article{Wang2025,
author = {Wang, Tianci and Lai, Xin and Wang, Shenjie and Liu, Yuqian and Zhu, Xiaoyan and Wang, Jiayin},
title = {MRDagent: iterative and adaptive parameter optimization for stable ctDNA-based MRD detection in heterogeneous samples},
journal = {Bioinformatics},
year = {2025},
doi = {10.1093/bioinformatics/btaf485}
}
EUVIMED